mous carcinoma cell line, FaDu cells subjected to peroxynitrite, as well as to probe into its role in this toxic process. METHOD: FaDu cells were cultured in vitro and subjected to different concentrations of peroxynitrite. The viability of FaDu cells in response to peroxynitrite was measured by MTT assay. The morphological changes were examined by acridine orange staining and, also, Ho33342/PI double staining in order to detect whether a cell experienced programmed cell death to this toxic insult. In particular, the changes in the expression of PDCD4 gene at both mRNA and protein levels were measured by the means of RT-PCR and Western-blot simultaneously. RESULTS: Direct exposure of FaDu cells to peroxynitrite was able to block the cell proliferation, which was further confirmed via the apoptotic pathway. Under such an oxidative stress, the expression of PDCD4 gene was apparently increased at both mRNA and protein levels. CONCLUSION: The present study demonstrates that PDCD4 gene may play an important role in peroxynitrite-induced programmed cell death in FaDu cells, which may offer a new target for the treatment of hypopharyngeal squamous carcinoma.
PET-CT and Detection of the Asymptomatic Recurrence
Katherine Fernandez, BS (presenter); Daniel Wehrmann, BS; Medhat Osman, MD, PhD OBJECTIVE: The role of follow up and detection of recurrent disease in cancer management remains to be defined. We recently reported the effectiveness of FDG PET-CT in detecting an asymptomatic recurrence in a group of previously treated head and neck cancer patients. This report is a follow up study reporting the survival outcomes in this group once the recurrence was detected. METHOD: A retrospective review was performed on a series of head and neck cancer patients (nϭ123) at a single institution between 2/18/04 to 7/09/07 who had undergone non-staging FDG-PET-CT scans as an integral part of the patients follow up after definitive treatment. Each scan (nϭ308) was evaluated by a board-certified nuclear medicine physician and final scan readings from each patients medical record were reviewed for this study. RESULTS: Of the 308 scans evaluated, 28 (9%) detected 32 lesions that represented asymptomatic disease. Asymptomatic lesions were detected most frequently at distant sites with 59% being thoracic, but also included primary (9%) and regional (19%) sites. These lesions were found in 23 (18%) of the patients evaluated. Of the 23 patients in whom an asymptomatic recurrence was detected 9 remain alive, 5 with disease (one had a subsequent recurrence treated and is currently disease free). The remainder of the group has died of malignant disease. CONCLUSION: PET-CT scanning is an effective tool for detecting asymptomatic recurrence in patients treated for head
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